SEARCH

SEARCH BY CITATION

References

  • 1
    Dickson RC , Everhart JE , Lake JR et al . Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database . Gastroenterology 1997 ; 113 : 16681674 .
  • 2
    Bonatti H , Machicao V , Dickson RC , Mendez J . Results of liver transplantation in HBV core antibody positive individuals and recipients of allografts from HBV core antibody positive donors . Eur Surg 2005 ; 37 : 15 .
  • 3
    Roche B , Samuel D , Gigou M et al . De novo and apparent de novo hepatitis B virus infection after liver transplantation . J Hepatol 1997 ; 26 : 517526 .
  • 4
    Douglas DD , Rakela J , Wright TL , Krom RA , Wiesner RH . The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient . Liver Transpl Surg 1997 ; 3 : 105111 .
  • 5
    Roque-Afonso AM , Feray C , Samuel D et al . Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors . Gut 2002 ; 50 : 9599 .
  • 6
    Manzarbeitia C , Reich DJ , Ortiz JA , Rothstein KD , Araya VR , Munoz SJ . Safe use of livers from donors with positive hepatitis B core antibody . Liver Transpl 2002 ; 8 : 556561 .
  • 7
    Chen YS , Wang CC , de Villa VH et al . Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors . Clin Transplant 2002 ; 16 : 405409 .
  • 8
    Wachs ME , Amend WJ , Ascher NL et al . The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors . Transplantation 1995 ; 59 : 230234 .
  • 9
    Dodson SF , Issa S , Araya V et al . Infectivity of hepatic allografts with antibodies to hepatitis B virus . Transplantation 1997 ; 64 : 15821584 .
  • 10
    Uemoto S , Sugiyama K , Marusawa H et al . Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants . Transplantation 1998 ; 65 : 494499 .
  • 11
    Prieto M , Gomez MD , Berenguer M et al . De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population . Liver Transpl 2001 ; 7 : 5158 .
  • 12
    Nery JR , Nery-Avila C , Reddy KR et al . Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine . Transplantation 2003 ; 75 : 11791186 .
  • 13
    Maguire D , Heaton ND , Smith HM . Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients . Transplantation 2002 ; 73 : 481482 .
  • 14
    Abdelmalek MF , Pasha TM , Zein NN , Persing DH , Wiesner RH , Douglas DD . Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure . Liver Transpl 2003 ; 9 : 12531257 .
  • 15
    Jain A , Orloff M , Abt P et al . Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine . Transplant Proc 2005 ; 37 : 31873189 .
  • 16
    Germer JJ , Charlton MR , Ishitani MB , Forehand CD , Patel R . Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant . Am J Transplant 2003 ; 3 : 743753 .
  • 17
    Oon CJ , Chen WN , Lim N et al . Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ‘a’ epitope of the surface antigen are sensitive to ganciclovir . Antiviral Res 1999 ; 41 : 113118 .
  • 18
    Horlander JC , Boyle N , Manam R et al . Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation . Am J Med Sci 1999 ; 318 : 304307 .
  • 19
    Ozaki T , Mochizuki H , Ichikawa Y , Fukuzawa Y , Yoshida S , Morimoto M . Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine: A 3-year follow-up study . J Oral Sci 2000 ; 42 : 147150 .
  • 20
    Rosen E , Rudensky B , Paz E et al . Ten-year follow-up study of hepatitis B virus infection and vaccination status in hospital employees . J Hosp Infect 1999 ; 41 : 245250 .
  • 21
    Barnas GP , Hanacik LJ . Hepatitis B vaccine: Persistence of antibody following immunization . Infect Control Hosp Epidemiol 1988 ; 9 : 147150 .
  • 22
    Bertoletti A , Southwood S , Chesnut R et al . Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18–27: Interaction with HLA and T-cell receptor . Hepatology 1997 ; 26 : 10271034 .
  • 23
    Rehermann B , Pasquinelli C , Mosier SM , Chisari FV . Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection . J Clin Invest 1995 ; 96 : 15271534 .
  • 24
    Shimada N , Yamamoto K , Kuroda MJ et al . HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells . J Clin Immunol 2003 ; 23 : 223232 .
  • 25
    Boni C , Penna A , Bertoletti A et al . Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B . J Hepatol 2003 ; 39 : 595605 .
  • 26
    Morita Y , Hosokawa M , Ebisawa M et al . Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A(*)02 or HLA-A(*)24 phenotype undergoing hematopoietic stem cell transplantation . Bone Marrow Transplant 2005 ; 36 : 803811 .
  • 27
    Macedo C , Donnenberg A , Popescu I et al . EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients . Transpl Immunol 2005 ; 14 : 109116 .
  • 28
    Maini MK , Boni C , Ogg GS et al . Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection . Gastroenterology 1999 ; 117 : 13861396 .
  • 29
    Katsurada A , Marusawa H , Uemoto S , Kaburagi A , Tanaka K . Circulating antibody to hepatitis B core antigen does not always reflect the latent hepatitis B virus infection in the liver tissue (abstract) . Gastroenterology 2002 ; 122 : 219A .
  • 30
    Loss GE , Jr. , Mason AL , Nair S et al . Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors? Liver Transpl 2003 ; 9 : 12581264 .
  • 31
    Fabrega E , Garcia-Suarez C , Guerra A et al . Liver transplantation with allografts from hepatitis B core antibody-positive donors: A new approach . Liver Transpl 2003 ; 9 : 916920 .
  • 32
    Marusawa H , Uemoto S , Hijikata M et al . Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen . Hepatology 2000 ; 31 : 488495 .
  • 33
    Munoz SJ . Use of hepatitis B core antibody-positive donors for liver transplantation . Liver Transpl 2002 ; 8 : S82S87 .
  • 34
    Burton JR , Jr. , Shaw-Stiffel TA . Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: A survey of current practice in the United States . Liver Transpl 2003 ; 9 : 837842 .
  • 35
    Yu AS , Vierling JM , Colquhoun SD et al . Transmission of hepatitis B infection from hepatitis B core antibody–positive liver allografts is prevented by lamivudine therapy . Liver Transpl 2001 ; 7 : 513517 .
  • 36
    Dodson SF . Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors . Clin Transplant 2000 ; 14 ( Suppl. 2 ): 2024 .
  • 37
    Holt D , Thomas R , Van Thiel D , Brems JJ . Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation . Arch Surg 2002 ; 137 : 572575 ; discussion 575–576 .
  • 38
    Lai CL , Dienstag J , Schiff E et al . Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B . Clin Infect Dis 2003 ; 36 : 687696 .
  • 39
    Roche B , Samuel D . Evolving strategies to prevent HBV recurrence . Liver Transpl 2004 ; 10 : S74S85 .
  • 40
    de Villa VH , Chen YS , Chen CL . Hepatitis B core antibody-positive grafts: Recipient's risk . Transplantation 2003 ; 75 : S49S53 .
  • 41
    Segovia R , Sanchez-Fueyo A , Rimola A et al . Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation . Liver Transpl 2001 ; 7 : 106112 .